𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Vasculitic complications of interferon-α treatment for chronic hepatitis C virus infection: case report and review of the literature

✍ Scribed by Wilke Beuthien; Hans-Ullrich Mellinghoff; Johannes von Kempis

Publisher
Springer
Year
2005
Tongue
English
Weight
271 KB
Volume
24
Category
Article
ISSN
0770-3198

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon antibodies may negate the ant
Interferon antibodies may negate the antiviral effects of recombinant α-interferon treatment in patients with chronic hepatitis B virus infection
✍ Dr. Anna Suk-Fong Lok; Ching-Lung Lai; Elsie Kit-Yee Leung 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 508 KB

In a randomized controlled trial of recombinant a-2a interferon for chronic hepatitis B, interferon antibodies developed in 21 (39%) of 54 Chinese adults who received IFN. No correlation was observed between sex, age, pretreatment serum ALT level or liver histological findings and the development of

Case report: Cure of chronic infection w
Case report: Cure of chronic infection with hepatitis C virus after 6 weeks of peg-interferon and ribavirin in a patient co-infected with HIV
✍ Anne Rachline; Pierre Palmer; François Simon; Jean-Michel Molina 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

## Abstract The recommended treatment duration of chronic hepatitis C virus (HCV) in patients infected with human immunodeficiency virus (HIV) is 48 weeks. This report describes a patient co‐infected with HCV genotype 2 and HIV who discontinued HCV therapy after 6 weeks because of adverse events an